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Abbreviation list 
ALPL/TNAP (gene/protein), tissue-nonspecific alkaline phosphatase isozyme 
ANKH/ANKH (gene/protein), progressive ankylosis protein homolog 
CM, calcifying medium 
ENPP1/PC1 (gene/protein), ectonucleotide pyrophosphatase/phosphodiesterase family 
member 1 
MGP, Matrix Gla Protein 
Pi, inorganic phosphate 
PPi, inorganic pyrophosphate 
PXE, Pseudoxanthoma elasticum 
SPP1/OPN (gene/protein), osteopontin 
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Abstract  
Background. Pseudoxanthoma elasticum (PXE) is a genetic disorder characterized by 
progressive calcification of soft connective tissues. The pathogenesis is still hard to pin down. 
In PXE dermal fibroblasts, in addition to impaired carboxylation of the vitamin K-dependent 
inhibitor matrix Gla protein (MGP), we have also demonstrated an up-regulation of alkaline 
phosphatase activity. In the light of these data we have suggested that both calcium and 
phosphate metabolism might be locally altered, both pathways acting in synergy on the 
occurrence of  matrix calcification. 
Objective. This study aims to better explore if cultured PXE fibroblasts, compared to 
control cells, exhibit a modified inorganic pyrophosphate (PPi) metabolism and are more 
responsive to pro-calcifying stimuli. 
Methods: Primary human dermal fibroblasts isolated from healthy individuals and from 
PXE patients were cultured for different time points in standard and in pro-calcifying 
media. The expression of ANKH/ANKH, ENPP1/PC1, ALPL/TNAP, SPP1/OPN were 
evaluated by PCR and Western blot, respectively. TNAP activity was measured by 
spectrophotometric analyses, whereas calcification was investigated by light and electron 
microscopy as well as by micro-analytical techniques. 
Results. In the presence of pro-calcifying stimuli, dermal fibroblasts alter their phenotype 
favouring matrix mineralization. In particular, ENPP1/PC1 and SPP1/OPN expression, as 
well as TNAP activity, were differently expressed in control and in PXE fibroblasts. 
Moreover, in pathologic cells the ratio between factors favouring and reducing PPi 
availability exhibit a more pronounced shift towards a pro-calcifying balance.  
Conclusion. PXE fibroblasts are more susceptible to pro-calcifying stimuli and in these 
cells an altered PPi metabolism contributes to matrix calcification. 
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Introduction 
Ectopic calcification is a deleterious and worldwide complication affecting soft 
connective tissues [1]. In the last decade, the involvement of numerous genes/proteins 
has been disclosed in a number of investigations, indicating that pathologic 
mineralization is the result of an active and dynamic balance of pro- and anti-calcifying 
mechanisms [2,3]. Never the less, there are no therapeutic options capable to efficiently 
inhibit the occurrence of ectopic calcification [4], suggesting that at least some of the 
pathogenetic mechanisms are still elusive and need to be further explored.  
Within this context, Pseudoxanthoma elasticum (PXE), an autosomal recessive disorder 
mainly affecting skin, eyes and the cardiovascular system, is typically characterized by 
a progressive mineralization of the elastic component of soft connective tissues [5] 
without any clear evidence of inflammation, cell necrosis or apoptosis [6]. Moreover, in 
PXE, in the absence of increased circulating levels of calcium and phosphate [7], 
calcified elastic fibres have a calcium/phosphate ratio similar to that of physiologically 
mineralized tissues as bone [8]. Surprisingly, PXE is associated to mutations in the 
ABCC6 gene [9] that encodes for a transmembrane protein highly expressed in liver and 
kidney, whereas it is barely detectable in soft connective tissues [6]. Clinical data and 
experimental observations indicate that, in PXE, ectopic calcification is not a passively 
diffused phenomenon, but affects peculiar matrix components in specific anatomical 
areas, although the pathogenetic mechanisms are still elusive. It has been suggested that 
elastic fibre calcification is the result of altered regulatory mechanisms that, possibly 
mediated or induced by factors abnormally released from the liver [6, 10-12], may 
influence mesenchymal cells. These cells are responsible for triggering soft connective 
tissue mineralization in defined areas and not in the whole matrix, as it would occur 
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simply due to the presence of altered circulating levels of calcium and phosphate and/or 
of other systemic factors [13-15]. At least in the skin, fibroblasts should be considered 
the principal candidates for the occurrence and progression of dermal ectopic 
calcification [16].  
In previous in vitro studies, we have demonstrated that PXE fibroblasts are unable to 
properly carboxylate matrix Gla protein (MGP) [7,17-18], a potent vitamin K-dependent 
inhibitor of calcium deposition [19] and are characterized by increased alkaline 
phosphatase activity [7]. However, up-regulated TNAP activity is necessary, but not 
sufficient, to induce the mineralization process, as demonstrated in in vitro standard cell 
culture conditions [18]. An appropriate ratio between inducers and inhibitors of 
calcifications (either present in serum supplemented media or produced by cells) is in 
fact required to have hydroxyapatite actively deposited on the cellular monolayer [7, 20].  
Aim of this study was to investigate whether primary human dermal fibroblasts from 
PXE patients are more responsive to pro-calcifying stimuli than control cells from 
healthy individuals. Moreover, we have investigated if these fibroblasts exhibit a 
differential expression of genes/proteins involved in the inorganic pyrophosphate (PPi) 
metabolism (i.e. progressive ankylosis protein homolog, ANKH/ANKH; ectonucleotide 
pyrophosphatase/phosphodiesterase family member 1, ENPP1/PC1; tissue-non specific 
alkaline phosphatase isozyme, ALPL/TNAP). Moreover, given the regulatory role of 
PC1, ANKH and TNAP on osteopontin (SPP1/OPN) [21], the expression of this 
inhibitor of mineral crystal growth [22-23] was also investigated.  
To address these questions, cells were cultured in standard (DMEM) and in calcifying 
media (CM) (i.e. in the absence/presence of calcifying stimuli, respectively) and 
evaluated at early and late time points (8 hours and 20 days, respectively). These two 
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time points were selected with the aim to investigate i) if changes occurring in cells well 
before mineral deposition takes place could be indicative of a particular susceptibility of 
cells to pro-calcifying stimuli, and ii) if the mineralizing environment provides a source 
of signalling cues that may further influence cell phenotype.  
 
Materials and Methods 
 
Cells 
Human dermal fibroblasts were available from the cell bank at the Cell-Lab “Paolo 
Buffa” (University of Modena and Reggio Emilia, Modena - Italy), being collected 
along the years in accordance with the guidelines of the ethical committee of the local 
Faculty of Medicine. Briefly, fibroblasts were isolated from skin biopsies, cultured in 
DMEM (Gibco, Grand Island, New York, USA) with 10% foetal bovine serum (FBS) 
(Lonza, Basel, CH), and stored in liquid nitrogen until use [24].  
Cells were from 8 clinically healthy females (41 ± 8 years), who did not exhibit any 
sign of genetic, metabolic or connective tissue disorders, and from 10 patients affected 
by PXE (44 ± 11 years), as demonstrated by clinical and biomolecular (ABCC6 
mutations).  
During all experimental procedures, fibroblasts from each individual were kept separate 
and used between 3rd and 8th passages. In each experiment, control and pathologic cells 
were used at the same passage. Cells were routinely cultured in 75cm2 flasks (Nunc, 
Roskilde, Denmark) with DMEM supplemented with 10% FBS, penicillin 100Ul/ml, 
streptomycin 100 μg/ml and non-essential aminoacids 1X (Gibco). At confluence, all 
fibroblasts were further cultured in standard medium (i.e. DMEM plus 10% FBS) 
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(DMEM) or in a more complex calcifying medium (CM) (i.e. DMEM supplemented 
with 10mM β-glycerophosphate, 50μg/ml ascorbic acid and 10nM dexamethasone 
(Sigma-Aldrich, Milan, Italy) [7]. Media were replaced three times a week. 
 
In vitro calcification: von Kossa staining and analysis by Environmental Scanning 
Electron Microscopy (ESEM) and X-ray Energy Dispersive Spectroscopy (EDS). 
Fibroblasts were routinely cultured in six-well plates (BD-Falcon, Franklin Lakes, NJ) 
up to confluence, when CM replaced the standard medium. At different time points, 
cells were fixed in 4% paraformaldehyde, stained with 2.5% silver nitrate, placed under 
a UV lamp for 30 min and rinsed with distilled water before treatment with 5% sodium 
thiosulfate for two minutes. Von Kossa-positive (black) deposits were observed after 
alcohol washes. Mineralized areas were quantified using the Image J software. 
Experiments were conducted two times on all cell lines. At the same time, parallel 
cultures were fixed in methanol for 10 min and then samples were observed with a 
scanning electron microscope (FEI-ESEM Quanta 200) (FEI, Hillsboro, OR, USA) in 
Low Vacuum mode. Solid State Detector (SSD) for backscattered electrons and Large 
Field Detector (LFD) for secondary electrons were used for imaging. Microanalysis was 
performed using X-EDS (Oxford - INCA-350)(Oxford Instruments, Austin, TX, USA) 
[8]. 
 
Tissue non specific alkaline phosphatase isozyme activity 
Fibroblasts were detached by enzymatic treatment and washed three times with PBS. 
Cells were lysed by appropriate buffer containing 0.1% Triton X-100 (Sigma). Cell 
lysate (20PL) was mixed with 100µL Tris-glycine buffer pH 10.3 (50mM Tris-HCl, 
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100mM glycine and 2mM MgCl2) and 100 µL of p-nitrophenyl phosphate (Sigma). The 
reaction mix was incubated at 37°C for 30 min and the reaction stopped by adding 50µl 
of 3M NaOH. Absorbance was measured at 405 nm in a microplate reader. Enzymatic 
activity was normalized to cell number. Control samples were set at 1. Experiments 
were performed at least three times in triplicate. 
 
RNA preparation and quantitative real-time PCR (qRT-PCR). 
Confluent cells were cultured in DMEM or in CM for a short (8 hours, i.e. early CM) 
and a longer length of time (20 days, i.e. late CM). At each time point, total cellular 
RNA was extracted using RNAeasy Protect cells Mini kit reagent (Qiagen, Valencia, 
CA) following manufacturer’s instructions. Quality and quantity of RNA were checked 
with a spectrophotometer and by agarose gel electrophoresis. cDNA was then reverse-
transcribed from 3 Pg of total RNA using superscript III Reverse Transcriptase 
(Invitrogen. Monza, Italy). The amplification efficiency of primers was between 95% 
and 105% [25]. Primers and their characteristics are listed in Table 1. A 3x diluted 
cDNA sample was further amplified on a iCycler (BioRad, Segrate, Italy) using SYBR® 
GreenERTMqPCR SuperMix (Invitrogen), according to manufacturer’s instructions. 
Thermal cycling parameters were set at 95°C for 5 min, 40 cycles at 95°C for 15 sec, an 
annealing temperature of 60°C for 30 sec, and of 72°C for 15 sec, followed by melting 
curve analysis with a temperature ranging from 95°C to 55°C. 
Gene expression in each sample was normalized to the expression of a housekeeping 
gene (CLK2) that has been considered more suitable for determinations in dermal 
fibroblasts [26]. Data were evaluated using the Pfaffl method [27] based on real-time 
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PCR efficiencies and compared with control cells. All qRT-PCR analyses were carried 
out in triplicate.  
 
Protein extraction and Western blot (WB)  
Cells were homogenized in RIPA buffer with protease inhibitors (Sigma), centrifuged 
and supernatants collected and stored at −80°C until analysis. Protein concentration was 
measured in each sample according to Bradford assay [28] in order to load equal 
amounts of proteins. After separation by 1D PAGE [18], proteins were transferred to 
nitrocellulose and incubated with primary antibodies and thereafter with appropriate 
horseradish peroxidase (HRP)-conjugated secondary antibodies (Abcam, Cambridge, 
UK). The following primary antibodies against ANKH (Abcam), OPN (Abcam), PC1 
(Santa Cruz Biotechnology, Santa Cruz, CA, USA), TNAP (Santa Cruz Biotechnology), 
Eactin (Sigma) and S100A4 (Abcam) were used. Experiments were performed at least 
two times with all different cell lines. 
 
Statistical analysis 
Values were analysed by Mann Whitney and by Anova test with significance at p<0.05. 
Statistical data were obtained using GraphPad software 5.0 (San Diego, CA, USA). 
 
Results  
In order to induce mineralization in vitro, fibroblasts, as all other mesenchymal cells, 
must be cultured in a pro-calcifying medium that provides cells of the appropriate 
environment [20].  
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Mineral deposits were characterized by environmental scanning electron microscopy 
(ESEM) and by micro-analytical analyses. By ESEM, calcification appeared as small 
round precipitates that, with time in culture, coalesced into bigger areas of 
mineralization (figure 1A, C, D). However, even after 40 days of culture in CM, mineral 
deposits were not spread all over the cellular monolayer, but there were areas in which 
cells were devoid of mineral precipitates (figure 1C, D). EDS spectra (figure 1B) 
demonstrated that calcified areas were made of calcium and phosphate, whose 
concentration was proportional to the presence and to the size of precipitates (figure 1 
B), thus confirming that, although in an in vitro experimental model, the mineralization 
process mimic what takes place in vivo [8]. Comparable data were obtained on cell 
cultures from PXE patients (figure 1) and from control individuals (data not shown). 
The extent of calcification was evaluated in control and PXE fibroblasts by light 
microscopy after the von Kossa staining (figure 2). As already demonstrated [7], cells 
cultured in DMEM never exhibited mineral deposition that, on the contrary, occurred in 
the presence of CM starting around day 20 and then progressively increased (figure 2). 
Crystal deposition was rather heterogeneous on the cellular monolayer with a variability 
being highly dependent on cell strain. Consistently, some PXE fibroblast cell strains 
exhibited a more extended surface area covered by mineral precipitates compared to 
control cells (figure 2). 
It has been reported that culturing cells in CM affects mesenchymal cell phenotype by 
changing the expression of cytoskeletal and calcium binding proteins [29-30], actin and 
S100A4 were therefore analysed by Western blot on fibroblasts cultured in DMEM and 
in CM at early and late time points (8 hours and 20 days, respectively). Both actin and 
S100A4 were expressed in all culture conditions and in all cell strains. Interestingly, 
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their expression significantly decreased after several days in CM (figure 3), 
demonstrating that these proteins were down-regulated when cells were actively 
involved in matrix calcification and that fibroblasts modified their phenotype in a 
mineralized environment. 
Since we have demonstrated that TNAP activity is up-regulated in PXE, it was 
suggested that phosphate metabolism may be locally altered, thus contributing to the 
mineralization process [7]. Pyrophosphate-related gene and protein expressions were 
therefore investigated on control and PXE fibroblasts. Cells were cultured in a pro-
calcifying environment in order to disclose, in an in-vitro system, whether PXE 
compared to control fibroblasts were more responsive to mineralization stimuli.  
No significant differences in the expression of ANKH/ANKH, ENPP1/PC1, 
ALPL/TNAP were detected at mRNA and protein levels in all cell strains cultured in 
DMEM (data not shown), in agreement with the inability of cells to calcify in these in 
vitro experimental conditions. By contrast, control fibroblasts cultured in CM at early 
and late time points revealed that, compared to basal levels of expression (i.e. confluent 
cells in DMEM), ENPP1/PC1 expression was significantly up-regulated at a late time 
point, when mineralization takes place (figure 4). Differences in ANKH, and ALPL 
expression were negligible at all time points (figure 4). 
A similar trend was observed also in PXE fibroblasts (figure 5), however, compared to 
basal levels, PC1 expression was significantly down- and up-regulated at early and late 
time points, respectively.  
Comparison of control and PXE fibroblasts (figure 6) revealed that PXE cells, at the 
early time point in CM, had a significant down-regulation of PC1 expression, whereas 
values were similarly up-regulated in all cell strains at later time points (figure 6B). 
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Differences in ANKH expression were negligible in all experimental conditions (figure 
6A). As already suggested [7], the mineralization process, at least in vitro, is associated 
to a progressive up-regulation of TNAP activity. In agreement with these observations, 
in the present study enzyme activity was progressively up-regulated in all cell strains 
(figure 6C), but values were significantly higher in PXE compared to control 
fibroblasts. Furthermore, since calcification is the results of a ratio between inducers 
and inhibitors of the mineralization process, including those regulating PPi, in figure 6D 
is shown the ratio between factors involved in PPi production and transport and factors 
that utilize PPi as a substrate for Pi release. This ratio, taken as an indicator of the 
mineralization potential of cells, appeared to progressively decrease as mineralization 
takes place in both cell lines. Interestingly, PXE cells have significantly lower values 
than control fibroblasts (figure 6D).  
In the extracellular milieu, osteopontin acts as a calcification inhibitor whose expression 
can be modulated by phosphate and pyrophosphate availability and by TNAP activity 
[21, 31-32]. SPP1 expression was significantly down-regulated in control and PXE 
fibroblasts at early time point in CM (figure 7A, C). Moreover, OPN expression, at 
early time point, was significant reduced in PXE compared to control cells (figure 7E), 
but it appeared increased up to basal levels in all cell strains at late compared to early 
time points (figure 7B, D). 
 
Discussion 
Pseudoxanthoma elasticum (PXE) is a genetic disease characterized by progressive 
ectopic calcification in soft connective tissues, including the skin [6]. In these patients, 
plasma levels of calcium and phosphate are normal, suggesting that other mechanisms 
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are involved in the control of mineralization [7]. We have previously shown that, in the 
absence of any altered value in the circulation, TNAP activity is up-regulated in PXE 
fibroblasts and that levamisole, a specific TNAP inhibitor, suppresses mineralization in 
vitro.  Therefore, it was hypothesized that in these cells, in addition to impaired MGP 
carboxylation, a modified PPi metabolism contributes to soft connective tissue 
calcification [7]. In agreement with this hypothesis, fibroblasts, being mesenchymal 
cells responsible for the correct amount and the appropriate quality of cellular and 
extracellular proteins, regulate the local balance of mineralization inducers and 
inhibitors and therefore can be advantageously used as an in vitro experimental model 
[16]. 
The present work aimed to study the effects of a pro-calcifying environment on control 
and PXE dermal fibroblasts by specifically looking at changes in the expression of 
genes and proteins involved in PPi metabolism. In particular, we have investigated the 
expression of PC1 that generates PPi from nucleoside triphosphates, of ANKH that 
mediates intracellular to extracellular PPi transport and of TNAP that hydrolyses PPi 
[21]. 
As already demonstrated, a standard cell culture environment is unsuitable to promote 
mineralization in vitro, independently from the ability of cells to induce calcification in 
vivo [33]. Consistently, in the present study, even after a long time of culture in DMEM, 
fibroblasts maintained their phenotype and mineralization never occurred. Moreover, 
the expression of mineralization-related genes/proteins regulating PPi metabolism 
exhibited negligible differences at various time points in culture as well as between 
control and PXE fibroblasts.  
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Therefore cells were cultured in an appropriate pro-calcifying environment that 
provides the stimuli necessary to induce the mineralization process in vitro [20, 34]. In 
order to avoid the passive mineral deposition that, upon inorganic phosphate 
supplementation, was demonstrated in vitro, even without cells [35], a complex medium 
containing ascorbic acid, E-glycerophosphate and dexamethasone was used [7, 20]. 
When cells were cultured in this pro-calcifying environment, there was a progressive 
hydroxyapatite deposition, even though mineralization was not homogeneously 
distributed over the monolayer.  Calcification, in fact, is not a passive phenomenon and 
cells, even in the same environment, are actively and differently responsive to 
mineralization stimuli [20]. Present findings could explain why, in PXE, calcification 
occurs in specific areas in the absence of higher circulating levels of calcium and 
phosphate and without any evidence of inflammation or cell death.  
The continuous presence of pro-calcifying stimuli is associated to cellular phenotypic 
changes [29-30]. In the present study, at later time points, fibroblasts reveal a 
cytoskeletal reorganization with reduced actin expression. Moreover, S100A4, a 
calcium-binding protein known to exert an inhibitory role on mineral deposition [29], 
was decreased to undetectable levels when the mineralized matrix is formed, indicating 
that calcification comes by changes in fibroblasts’ behaviour.  
Surprisingly, at early time points, before mineralization and before changes in 
fibroblasts’ phenotype, PXE compared to control cells were characterized by 
significantly reduced expression of PC1 and increased TNAP activity. These changes 
act in synergy reducing the availability of PPi, a condition that represents a prerequisite 
for the mineralization process to take place [36].  Like PPi, OPN is a potent inhibitor of 
hydroxyapatite crystal growth [22-23]. Moreover, it has been demonstrated in 
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osteoblasts that PPi is a specific signal for the induction of OPN expression [32] and 
that PPi deficiency in ENPP1-/- mice results in OPN deficiency [31]. In agreement with 
these observations a down-regulation of OPN has been demonstrated in PXE 
fibroblasts.  
The altered expression of PPi-related proteins, as clearly shown at the early time point, 
indicates that PXE compared to control fibroblasts are particularly sensitive to a pro-
calcifying environment. 
At late time points, in a mineralizing environment, both control and PXE cells exhibited 
a significant up-regulation of ENPP1/PC1 as an attempt to counteract the mineralization 
process. However, PPi is a substrate for TNAP, whose activity was significantly up-
regulated with time in CM, especially in PXE fibroblasts. After 20 days of culture, 
compared to the early time point in CM, OPN was up-regulated towards basal levels of 
expression.  
It has to be noted that at later time points, after several days in the presence of pro-
calcifying stimuli, the different response of control and PXE fibroblasts, observed at 
early time points, was no further detectable, being masked as a consequence of a 
secondary response of fibroblasts to the mineralized environment and/or of cumulative 
effects due to the extended permanence in CM.  
We are aware that these culture conditions represent an artificial system, as are all in 
vitro models, since they should mimic in shorter times (few days or weeks) what takes 
place in vivo along the years under complex regulatory mechanisms active at both local 
and systemic levels. Never the less, results demonstrate that in vitro, if an adequate 
availability of calcifying stimuli are provided to cells, fibroblasts promote mineral 
deposition. These events are only partly dependent of TNAP activity, since enzyme up-
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regulation per se is not sufficient to favour the calcification process, as demonstrated for 
instance in cells cultured in standard medium [7], even in the presence of higher levels 
of enzyme activity. Never the less, even in PXE fibroblasts cultured in DMEM, the ratio 
between inducers and inhibitors of PPi metabolism is already shifted towards a pro-
calcifying balance, suggesting that these cells may be more susceptible to 
mineralization stimuli compared to control fibroblasts. Mineralization takes place in all 
cell strains after several days in CM, when threshold levels of calcification inducers 
exceed that of inhibitors. However, PXE fibroblasts, although with a variability 
depending on cell strain, showed higher amount of mineralization, supporting the 
hypothesis that these cells are more responsive to calcifying stimuli. 
Moreover, it has to be underlined that in PXE, both in vivo and in vitro, the lower 
amount of carboxylated-MGP causes soft connective tissues being devoid of an 
appropriate and effective protection against mineral deposition [7, 17-18]. Therefore, in 
PXE, both reduced MGP carboxylation and altered PPi metabolism may synergistically 
contribute to ectopic calcification.  
In conclusion, mineralization may depend on fibroblast’s subtype behaviour and 
responsiveness [37], on matrix composition (both in terms of quality and quantity of 
secreted proteins as well as on proteolytic activities) [6, 38-40], on local calcium and 
phosphate availability [6] and on the ratio between mineralization inducers and 
inhibitors [7, 16]. Results demonstrate that changes in PPi metabolism are present in 
PXE fibroblasts. Moreover, the altered balance between factors promoting or reducing 
PPi availability is already present in standard culture conditions, thus turning PXE 
fibroblasts into cells more responsive to pro-calcifying stimuli compared to controls.  
Therefore, we propose that circulating factors abnormally released in the circulation 
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[10-12] are likely responsible for the development of a pro-calcifying environment that 
progressively induce responsive fibroblasts to alter their phenotype and to promote the 
mineralization process. 
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Legend to figures 
 
Fig. 1. Characterization of mineral deposits in dermal fibroblasts cultured in 
calcifying medium. Mineral deposits are visualized by ESEM on PXE fibroblasts after 
20 (A) and 40 days (C, D). Panel D shows, at higher magnification, the distribution of 
hydroxyapatite bright deposits (*) on the surface of elongated fibroblasts (arrow). EDS 
spectra (B) demonstrate that mineral deposits are made of calcium (Ca) and phosphate 
(P), whose levels are proportional to the size/amount of calcification.  
 
Fig. 2. Mineral deposition in control and PXE dermal fibroblasts cultured in 
calcifying medium. The extent of mineralization has been evaluated after von Kossa 
staining on control and PXE fibroblast cell cultures at different time points (from 10 up 
to 40 days). The percentage of calcified areas on the whole monolayer measured in each 
strain at same passages is shown. The increase of mineralization in control and PXE 
fibroblasts is time-dependent, as demonstrated by linear regression analysis (insert).   
 
Fig. 3. Western blot for actin and S100A4 protein expression.  Confluent cells were 
cultured for 8 hours (early time) and 20 days (late time) in standard (DMEM) and in 
calcifying (CM) media. Control (C) and PXE (P) fibroblasts at same passages are 
compared. A representative Western blot is shown in upper panel, whereas mean values 
from all cells strains ± SE are shown in histograms. **p<0.01; De (early time point in 
DMEM), CMe (early time point in CM); Dl (late time point in DMEM), CMl (late time 
point in CM). 
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Fig. 4. PPi-related gene and protein expression in control fibroblasts. RNA and 
protein expression of progressive ankylosis protein homolog (ANKH/ANKH), 
ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1/PC1) and 
of tissue-nonspecific alkaline phosphatase isozyme (ALPL/TNAP) were evaluated by 
RT-PCR and Western blot in control fibroblasts at confluence in standard medium 
(DMEM) (set at 1) and in calcifying medium (CM) for 8 hours (early) and 20 days (late). 
Data from two experiments performed in triplicate with all fibroblasts cell lines are 
expressed as box-and-whisker plots showing the range of mRNA and protein expression 
values. The horizontal line shows the median value for each experimental condition, 
boxes represent the inter-quartile range and whiskers indicate the full extent of 
minimum/maximum values. ** p<0.01 late vs. early times in CM;  ## p<0.01 CM vs. 
DMEM. 
 
Fig. 5. PPi-related gene and protein expression in PXE fibroblasts. mRNA and 
protein expression of progressive ankylosis protein homolog (ANKH/ANKH), 
ectonucleotide pyrophosphatase/phosphodiesterase family member 1 (ENPP1/PC1) and 
of alkaline phosphatase tissue-nonspecific isozyme (ALPL/TNAP) were evaluated by 
RT-PCR and Western blot in PXE fibroblasts at confluence in standard medium 
(DMEM) (set at 1) and in calcifying medium (CM) for 8 hours (early) and 20 days 
(late). Data from two experiments performed in triplicate with all fibroblasts cell lines 
are expressed as box-and-whisker plots showing the range of mRNA and protein 
expression values. The horizontal line shows the median value for each experimental 
condition, boxes represent the inter-quartile range and whiskers indicate the full extent 
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of minimum/maximum values. ** p<0.01 late vs. early times in CM;  # p<0.05, ## 
p<0.01 CM vs. DMEM. 
 
Fig. 6. PPi-related proteins in control and PXE fibroblasts. Control and PXE 
fibroblasts were cultured in standard medium (DMEM) (set at 1) and in calcifying 
medium (CM) for 8 hours (early) and 20 days (late). Expression levels of progressive 
ankylosis protein homolog (ANKH) (A) and of ectonucleotide 
pyrophosphatase/phosphodiesterase family member 1 (PC-1) (B), evaluated by Western 
blot, are expressed as box-and-whisker plots. The horizontal line shows the median 
value for each experimental condition, boxes represent the inter-quartile range and 
whiskers indicate the full extent of minimum/maximum values. TNAP activity (C) and 
the ratio (D) between factors increasing (PC1 and ANKH) and reducing (TNAP) PPi 
availability are expressed as mean values r SE. All data are from two experiments 
performed in triplicate with all fibroblasts cell lines at same passages. * p<0.05, ** 
p<0.01, *** p<0.001 late vs. early time point in CM; # p<0.05, ## p<0.01, ### p<0.001 
CM vs. DMEM; § p<0.05, §§ p<0.01 PXE vs. Control in the same culture condition. 
 
Fig. 7. Osteopontin gene and protein expression in control and PXE fibroblasts. 
mRNA and protein expression of osteopontin (SPP1/OPN) were evaluated by RT-PCR 
and Western blot in control (A, B) and in PXE (C, D) fibroblasts cultured in standard 
medium (DMEM) (set at 1) and in calcifying medium (CM) for 8 hours (early) and 20 
days (late). Comparison of OPN expression in control and in PXE fibroblasts at same 
passages is shown in panel E. Data from two experiments performed in triplicate with 
all fibroblasts cell lines are expressed as box-and-whisker plots. The horizontal line 
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shows the median value for each experimental condition, boxes represent the inter-
quartile range and whiskers indicate the full extent of minimum/maximum values. * 
p<0.05 late vs. early time points in CM; # p<0.05 CM vs. DMEM; § p<0.05 PXE vs. 
Control in the same culture condition. 
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TABLE 1.  Primes used for Real Time Polymerase Chain Reaction 
 
Gene  positions  Sequence 5’- 3’ Tm %GC slope E% R2 
  ALPL 
forward 
reverse 
 
1044-1066 
1108-1131 
 
TACAAGCACTCCCACTTCATCTG 
GCTCGAAGAGACCCAATAGGTAGT 
60 
 
47 
50 
-3.353 98.7 0.915 
ANKH 
forward 
reverse 
 
2268-2289 
2327-2351 
 
CACATGGCCGTACAAAGAGATG 
GTGTGGAGTAGATGGTTTCGAACTC 
60 
 
50 
48 
-3.426 95.8 0.920 
ENPP1 
forward 
reverse 
 
2107-2129 
2166-2192 
 
CCGTGGACAGAAATGACAGTTTC 
ATGGACAGGACTAAGAGGAATTCTAAA 
60 
 
47 
37 
-3.207 105 0.989 
SPP1 
forward 
reverse 
 
325-342 
398-415 
 
CTCCTAGCCCCACAGAAT 
GGTCATGGCTTTCGTTGG 
60 
 
56 
48 
-3.432 95.6 0.955 
CLK2 
forward 
reverse 
 
1295-1313 
1374-1394 
 
GCACCATAGCACCATTGTC 
GCAGCCTATACTCCACACATC 
60 
 
52 
52 
-3.354 98.7 0.978 
 
 
 
Table 1
